TSO3 Inc. (TSE:TOS) – Equities researchers at Desjardins decreased their FY2018 EPS estimates for shares of TSO3 in a research report issued to clients and investors on Thursday. Desjardins analyst F. Tremblay now anticipates that the company will post earnings of ($0.13) per share for the year, down from their previous estimate of ($0.07). Desjardins currently has a “Hold” rating and a $1.60 target price on the stock. Desjardins also issued estimates for TSO3’s FY2019 earnings at ($0.05) EPS.
A number of other brokerages also recently weighed in on TOS. National Bank Financial downgraded shares of TSO3 from an “outperform” rating to a “sector perform” rating and lowered their price objective for the company from C$5.50 to C$2.25 in a research report on Monday, January 29th. Canaccord Genuity downgraded shares of TSO3 from a “buy” rating to a “speculative buy” rating and lowered their price objective for the company from C$4.25 to C$2.75 in a research report on Friday, January 26th. Royal Bank of Canada downgraded shares of TSO3 from an “outperform” rating to a “sector perform” rating and lowered their price objective for the company from C$4.25 to C$2.00 in a research report on Friday, January 26th. Finally, Scotiabank lowered their price objective on shares of TSO3 from C$4.50 to C$2.75 and set an “outperform” rating on the stock in a research report on Tuesday, January 30th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. TSO3 presently has a consensus rating of “Hold” and a consensus price target of C$2.12.
TSO3 Company Profile
TSO3 Inc is a Canada-based company engaged in the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment.
Receive News & Ratings for TSO3 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSO3 and related companies with MarketBeat.com's FREE daily email newsletter.